Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition - MR PCI


The goal of the trial was to evaluate the effect on inhibition of platelet aggregation (IPA) of four antiplatelet regimens of different combinations of glycoprotein (GP) IIb/IIIa inhibitors and clopidogrel among patients undergoing elective, high-risk percutaneous coronary intervention (PCI).